4693 related articles for article (PubMed ID: 32793245)
1. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
2. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
3. Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
Vignesh R; Shankar EM; Velu V; Thyagarajan SP
Front Immunol; 2020; 11():586781. PubMed ID: 33101320
[No Abstract] [Full Text] [Related]
4. DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
Yu J; Tostanoski LH; Peter L; Mercado NB; McMahan K; Mahrokhian SH; Nkolola JP; Liu J; Li Z; Chandrashekar A; Martinez DR; Loos C; Atyeo C; Fischinger S; Burke JS; Slein MD; Chen Y; Zuiani A; Lelis FJN; Travers M; Habibi S; Pessaint L; Van Ry A; Blade K; Brown R; Cook A; Finneyfrock B; Dodson A; Teow E; Velasco J; Zahn R; Wegmann F; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kirilova M; Kordana N; Lin Z; Maxfield LF; Nampanya F; Nityanandam R; Ventura JD; Wan H; Cai Y; Chen B; Schmidt AG; Wesemann DR; Baric RS; Alter G; Andersen H; Lewis MG; Barouch DH
Science; 2020 Aug; 369(6505):806-811. PubMed ID: 32434945
[TBL] [Abstract][Full Text] [Related]
5. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
Shelly A; Gupta P; Ahuja R; Srichandan S; Meena J; Majumdar T
Viruses; 2020 Oct; 12(10):. PubMed ID: 33050511
[TBL] [Abstract][Full Text] [Related]
6. The false promise of herd immunity for COVID-19.
Aschwanden C
Nature; 2020 Nov; 587(7832):26-28. PubMed ID: 33087872
[No Abstract] [Full Text] [Related]
7. Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns.
Zellweger RM; Wartel TA; Marks F; Song M; Kim JH
Expert Rev Vaccines; 2020 Aug; 19(8):691-698. PubMed ID: 32838605
[TBL] [Abstract][Full Text] [Related]
8. Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection.
Simon HU; Karaulov AV; Bachmann MF
Int Arch Allergy Immunol; 2020; 181(8):624-628. PubMed ID: 32544911
[TBL] [Abstract][Full Text] [Related]
9. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.
Anderson RM; Vegvari C; Truscott J; Collyer BS
Lancet; 2020 Nov; 396(10263):1614-1616. PubMed ID: 33159850
[No Abstract] [Full Text] [Related]
10. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".
Kleen TO; Galdon AA; MacDonald AS; Dalgleish AG
Front Immunol; 2020; 11():2059. PubMed ID: 33013871
[TBL] [Abstract][Full Text] [Related]
11. Understanding COVID-19 vaccine efficacy.
Lipsitch M; Dean NE
Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
[No Abstract] [Full Text] [Related]
12. Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey.
Goldman RD; Yan TD; Seiler M; Parra Cotanda C; Brown JC; Klein EJ; Hoeffe J; Gelernter R; Hall JE; Davis AL; Griffiths MA; Mater A; Manzano S; Gualco G; Shimizu N; Hurt TL; Ahmed S; Hansen M; Sheridan D; Ali S; Thompson GC; Gaucher N; Staubli G;
Vaccine; 2020 Nov; 38(48):7668-7673. PubMed ID: 33071002
[TBL] [Abstract][Full Text] [Related]
13. From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development.
Ma C; Su S; Wang J; Wei L; Du L; Jiang S
Microbes Infect; 2020; 22(6-7):245-253. PubMed ID: 32437926
[TBL] [Abstract][Full Text] [Related]
14. Immunological considerations for COVID-19 vaccine strategies.
Jeyanathan M; Afkhami S; Smaill F; Miller MS; Lichty BD; Xing Z
Nat Rev Immunol; 2020 Oct; 20(10):615-632. PubMed ID: 32887954
[TBL] [Abstract][Full Text] [Related]
15. The race for coronavirus vaccines: a graphical guide.
Callaway E
Nature; 2020 Apr; 580(7805):576-577. PubMed ID: 32346146
[No Abstract] [Full Text] [Related]
16. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
[TBL] [Abstract][Full Text] [Related]
17. Could "trained immunity" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence.
Alsulaiman JW; Khasawneh AI; Kheirallah KA
J Infect Dev Ctries; 2020 Sep; 14(9):957-962. PubMed ID: 33031080
[TBL] [Abstract][Full Text] [Related]
18. Development of vaccines for SARS-CoV-2.
Ng WH; Liu X; Mahalingam S
F1000Res; 2020; 9():. PubMed ID: 32850116
[TBL] [Abstract][Full Text] [Related]
19. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
[No Abstract] [Full Text] [Related]
20. A vaccine is not too far for COVID-19.
Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
